Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LFSCNYSEARCA:RXLNYSEARCA:SBIONYSEARCA:SURI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLFSCF/m Emerald Life Sciences Innovation ETF$24.81+0.6%$23.67$18.78▼$27.76$55.57MN/A3,103 shs9 shsRXLProShares Ultra Health Care$41.02+0.2%$40.41$36.52▼$58.74$66.45M1.478,490 shs3,288 shsSBIOALPS Medical Breakthroughs ETF$30.85+0.7%$29.61$22.33▼$42.73$74.81M0.9212,446 shs2,354 shsSURISimplify Propel Opportunities ETF$14.98-0.9%$15.01$12.71▼$27.52$65.76M1.573,342 shs1,902 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLFSCF/m Emerald Life Sciences Innovation ETF0.00%+0.81%+1.64%+22.10%+2,480,999,900.00%RXLProShares Ultra Health Care0.00%+2.19%+1.48%-0.15%-17.71%SBIOALPS Medical Breakthroughs ETF0.00%+1.65%-2.31%+24.85%-6.40%SURISimplify Propel Opportunities ETF0.00%-3.35%-6.72%+12.21%-30.71%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/AN/AN/AN/AN/AN/AN/ASBIOALPS Medical Breakthroughs ETFN/AN/AN/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLFSCF/m Emerald Life Sciences Innovation ETF 2.92Moderate Buy$24.81N/ARXLProShares Ultra Health Care 2.68Moderate Buy$41.02N/ASBIOALPS Medical Breakthroughs ETF 2.91Moderate Buy$30.85N/ASURISimplify Propel Opportunities ETF 2.62Moderate Buy$14.98N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/AN/AN/AN/AN/ASBIOALPS Medical Breakthroughs ETFN/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLFSCF/m Emerald Life Sciences Innovation ETFN/AN/A0.00∞N/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/A24.86∞N/AN/AN/AN/AN/ASBIOALPS Medical Breakthroughs ETFN/AN/A0.00∞N/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLFSCF/m Emerald Life Sciences Innovation ETFN/AN/AN/AN/AN/ARXLProShares Ultra Health Care$0.631.54%N/AN/AN/ASBIOALPS Medical Breakthroughs ETF$1.173.79%N/AN/AN/ASURISimplify Propel Opportunities ETF$2.7218.16%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLFSCF/m Emerald Life Sciences Innovation ETFN/ARXLProShares Ultra Health CareN/ASBIOALPS Medical Breakthroughs ETFN/ASURISimplify Propel Opportunities ETFN/AInsider OwnershipCompanyInsider OwnershipLFSCF/m Emerald Life Sciences Innovation ETFN/ARXLProShares Ultra Health CareN/ASBIOALPS Medical Breakthroughs ETFN/ASURISimplify Propel Opportunities ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLFSCF/m Emerald Life Sciences Innovation ETFN/A2.24 millionN/AN/ARXLProShares Ultra Health CareN/A1.62 millionN/ANot OptionableSBIOALPS Medical Breakthroughs ETFN/A2.43 millionN/ANot OptionableSURISimplify Propel Opportunities ETFN/A4.39 millionN/ANot OptionableSURI, RXL, SBIO, and LFSC HeadlinesRecent News About These CompaniesSimplify Propel Opportunities ETF declares $0.68 dividendJune 30, 2025 | seekingalpha.comSimplify Propel Opportunities ETF declares quarterly distribution of $0.6800March 28, 2025 | seekingalpha.comHigh-Momentum ETFs Leading the Market This Year (SURI)...February 7, 2025 | marketbeat.comSimplify Provides Estimated Capital Gain Distribution Information for 2024November 27, 2024 | businesswire.com(SURI) Trading ReportNovember 7, 2024 | news.stocktradersdaily.comNSimplify Propel Opportunities ETF (SURI)October 20, 2024 | investing.comSURI Simplify Propel Opportunities ETFOctober 18, 2024 | seekingalpha.com(SURI) On The My Stocks PageOctober 16, 2024 | news.stocktradersdaily.comNBest-Performing ETFs of Last WeekSeptember 24, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRXL, SURI, SBIO, and LFSC Company DescriptionsF/m Emerald Life Sciences Innovation ETF NASDAQ:LFSC$24.81 +0.15 (+0.61%) As of 07/3/2025 02:20 PM EasternThe F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.ProShares Ultra Health Care NYSEARCA:RXL$41.02 +0.09 (+0.22%) As of 07/3/2025 05:00 PM EasternProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.ALPS Medical Breakthroughs ETF NYSEARCA:SBIO$30.85 +0.21 (+0.69%) Closing price 07/3/2025 05:00 PM EasternExtended Trading$30.83 -0.02 (-0.06%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.Simplify Propel Opportunities ETF NYSEARCA:SURI$14.98 -0.13 (-0.86%) As of 07/3/2025 05:00 PM EasternThe Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities SURI was launched on Feb 7, 2023 and is managed by Simplify. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
